News Hub | News Direct

News Release

Argo Living Soils (CSE: ARGO) (OTC: ARLSF): Positioned for Growth in a $31.35 Billion Industry

ARLSF/ARGO

The global sustainable agriculture market is on a rapid growth trajectory, fueled by increasing environmental awareness, regulatory backing, and a surging demand for organic products. Valued at $13.32 billion in 2022, the market is projected to more than double, reaching $31.35 billion by 2031, with a compound annual growth rate (CAGR) of 10.17%. This expansion is driven by critical factors such as climate change adaptation, global food security concerns, and the integration of circular economy principles into farming. As consumers and industries alike shift toward more eco-friendly and regenerative agricultural methods, companies leading in sustainable solutions are well-positioned to capitalize on this momentum. Argo Living Soils Corp. (CSE: ARGO) (OTC: ARLSF) is making strides in the sustainable agriculture sector. The company focuses on organic soil amendments, biofertilizers, and solutions that support more sustainable farming practices. With a growing range of eco-friendly products, expanding partnerships, and a focus on reducing chemical use in agriculture, Argo is positioning itself to meet the rising demand for sustainable agricultural solutions Innovating for a Sustainable Future Argo Living Soils is making waves in the sustainable agriculture sector, offering investors a unique opportunity to participate in a rapidly growing market. With a focus on organic soil amendments, biofertilizers, and eco-friendly farming solutions, Argo is well-positioned to capitalize on the increasing global demand for sustainable agricultural practices. The company’s recent strategic moves, including a groundbreaking partnership for biomass-to-graphene development, its entry into the green concrete market, and its application for an OTCQB listing, underscore its commitment to innovation, growth, and environmental stewardship. An Emerging Player in the Sustainable Agriculture Sector Argo Living Soils specializes in producing and developing organic products such as living soils, biofertilizers, and compost extracts tailored for high-value crops. The company’s mission is to create a brand synonymous with environmentally friendly farming solutions. Over the past month, Argo’s stock has surged by an impressive 281%, reflecting growing investor confidence in its business model and market potential. The company’s innovative approach to soil health addresses a critical need in modern agriculture. By reducing reliance on chemical fertilizers and pesticides, Argo’s products not only enhance crop yields but also promote environmental sustainability. This aligns with global trends, as governments, businesses, and consumers increasingly prioritize eco-friendly practices. OTCQB Listing: A Major Milestone On February 24, 2025, Argo announced that it has begun the process of listing its common stock on the OTCQB Venture Market, operated by OTC Markets Group. This move is expected to significantly enhance the company’s visibility and liquidity, providing greater access to its shares for a broader range of investors. Robert Intile, Argo’s CEO, emphasized the importance of this step, stating, “Listing on the OTCQB is an important step in our company’s growth. We believe that this listing will increase our visibility within the investment community, provide greater access to our shares for a broader range of investors, and enhance liquidity.” The OTCQB is a premier marketplace for developing companies, offering a cost-effective and efficient way to access the U.S. capital markets. To qualify, companies must meet stringent requirements, including current financial reporting, annual verification, and management certification. Argo’s application demonstrates its commitment to transparency and growth, further solidifying its appeal to investors. Strategic Partnerships and Expansion In October 2024, Argo entered into a research and development agreement with Connective Global to develop organic composted fertilizers and biomass-to-biochar soil additives. This collaboration aims to improve soil health while reducing carbon footprints, further solidifying Argo’s position as a leader in sustainable agriculture. More recently, Argo announced a memorandum of understanding (MOU) with PT. Aplikasi Grafena Industri & Consulting (AGIC) in Indonesia. This partnership focuses on building a commercial graphene R&D manufacturing facility for agricultural and industrial applications. Graphene, a revolutionary material known for its strength, conductivity, and versatility, has the potential to transform industries ranging from agriculture to construction. Robert Intile expressed enthusiasm about the partnership, stating, “We are excited to partner with AGIC, an innovative company that has created a low-cost way of producing high-quality graphene. Their patented technology can convert waste biomass into valuable graphene, which may revolutionize farming and industrial applications.” Entry into the Green Concrete Market Argo’s strategic vision extends beyond agriculture. In February 2025, the company announced plans to incorporate a new subsidiary, Argo Green Concrete Solutions Inc., in Nevada, USA. This venture will focus on developing environmentally friendly concrete solutions using bio-graphene derived from organic sources. The green concrete market represents a significant opportunity for Argo, as the construction industry seeks sustainable alternatives to traditional materials. Argo’s bio-graphene concrete is expected to be twice as strong and four times more water-resistant than conventional options, with the added benefit of reducing CO2 emissions. Financial Strength and Investor Confidence Argo’s recent financial developments further underscore its growth trajectory. The company successfully closed the final tranche of its non-brokered private placement, raising a total of $302,975. Additionally, Argo received $710,600 CDN from the exercise of warrants since February 1, 2025. These funds will support the company’s R&D efforts, market expansion, and strategic initiatives. Competitive Advantages and Future Outlook Argo’s commitment to innovation, strategic partnerships, and sustainable practices sets it apart from competitors. The company’s focus on R&D has led to groundbreaking advancements in soil health and green construction materials. Its leadership team, bolstered by recent appointments with expertise in biochar and Southeast Asian agriculture, is well-equipped to drive growth in emerging markets. As global demand for sustainable solutions continues to rise, Argo is poised to capitalize on these trends. Its partnerships with AGIC and Connective Global, coupled with its entry into the green concrete market and its OTCQB listing application, position the company for long-term success. Argo Living Soils Corp. (CSE: ARGO) (OTC: ARLSF) is expanding its footprint in sustainable agriculture with organic soil solutions, biofertilizers, and eco-friendly innovations. With strategic moves into graphene, green concrete, and capital markets, the company is positioned for long-term growth while advancing environmentally conscious solutions. As global demand rises, Argo remains a key player to watch. Disclaimers: RazorPitch Inc. "RazorPitch" is not operated by a licensed broker, a dealer, or a registered investment adviser. This content is for informational purposes only and is not intended to be investment advice. The Private Securities Litigation Reform Act of 1995 provides investors a safe harbor in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions, or future events or performance are not statements of historical fact may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements indicating certain actions & quote; may, could, or might occur. Understand there is no guarantee past performance will be indicative of future results. Investing in micro-cap and growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investors investment may be lost or impaired due to the speculative nature of the companies profiled. RazorPitch has been retained and compensated by Awareness Consulting to assist in the production and distribution of content related to ARLSF. RazorPitch is responsible for the production and distribution of this content. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. This content is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice. Nothing contained in this article constitutes a solicitation, recommendation, endorsement, or offer by RazorPitch or any third party service provider to buy or sell any securities or other financial instruments. All content in this article is information of a general nature and does not address the circumstances of any particular individual or entity. Nothing in this article constitutes professional and/or financial advice, nor does any information in the article constitute a comprehensive or complete statement of the matters discussed or the law relating thereto. RazorPitch is not a fiduciary by virtue of any persons use of or access to this content. Contact Details RazorPitch Mark McKelvie +1 585-301-7700 mark@razorpitch.com

February 25, 2025 07:00 AM Eastern Standard Time

Riding the Antimony Wave: 4 Stocks to Watch as Prices Hit Record Highs

MILIF, PPTA, UAMY, NVA

Antimony, a critical but often overlooked metal, has surged to a record $51,000 per ton, driven by tightening Chinese export controls and escalating global demand. Essential for military ammunition, missile systems, flame retardants, and advanced electronics, antimony plays a pivotal role in both national defense and modern industry. Yet, the global supply chain for this vital mineral is in crisis. With China and Russia controlling nearly 100% of global production, NATO and Western nations are dangerously exposed to supply disruptions. The war in Ukraine has further strained resources, depleting stockpiles and underscoring the West’s reliance on foreign suppliers. Without a stable antimony supply, efforts to ramp up military production and sustain industrial output face serious risks. For investors, this crisis has created a unique opportunity. Western-backed mining projects are now at the forefront of securing alternative antimony sources, with companies like Perpetua Resources (NASDAQ: PPTA), United States Antimony Corporation (NYSE: UAMY), Nevada Exploration (NASDAQ: NVA), and Military Metals Corp. (OTCQB: MILIF) leading the charge. As governments and industries race to secure supply, these firms are positioned to benefit from rising prices and increasing importance. Let’s take a closer look. Military Metals Corp.: As the global antimony supply crisis deepens, Military Metals Corp. (CSE: MILI) (OTCQB: MILIF) is emerging as a key player in the global antimony supply race, leveraging a portfolio of high-potential projects across North America and Europe to address the critical mineral shortage. With a portfolio of high-potential antimony-gold projects across North America and Europe, the company is strategically positioned to capitalize on soaring antimony prices, which recently hit a record $51,500 per tonne. Military Metals’ flagship Trojárová Antimony-Gold Project in Slovakia is a standout asset. Located just three kilometers from the historic Pezinok mine—once Europe’s largest antimony producer—Trojárová benefits from rich mining history and extensive historical data. The project was the focus of 63 drill holes totaling 14,300 meters and 1.7 kilometers of underground development in the 1980s, culminating in a historical resource estimate. The company is currently digitizing and georeferencing this data to build a 3D deposit model, paving the way for a NI 43-101 compliant resource estimate. As CEO Scott Eldridge noted, “We look forward to unlocking value as we examine the brownfield benefits of the property." With Slovakia’s legacy as a high-grade antimony producer, Trojárová represents a significant opportunity to revive a once-thriving mining region. In North America, Military Metals is advancing two additional projects: the West Gore Antimony-Gold Project in Nova Scotia and the Last Chance Antimony-Gold Project in Nevada. West Gore, a historically significant producer that contributed to the Allied war effort during World War I, recently expanded its land position by 388 hectares, consolidating the mineralized system for future exploration. Between 1914 and 1917, West Gore produced 7,000 tons of antimony concentrate, grading 46% antimony, alongside nearly 6,900 ounces of gold. The company plans to launch exploration programs at West Gore in Q2-Q3 2025, aiming to unlock the property’s full potential. Meanwhile, Last Chance, located just 18 kilometers west of Kinross’s Round Mountain gold mine in Nevada, offers modern exploration potential in a mining-friendly jurisdiction. The property has a rich history of antimony production dating back to 1880, with limited production supporting U.S. defense efforts until the 1960s. Military Metals completed its acquisition of Last Chance in February 2025 and has already conducted an initial field visit. CEO Scott Eldridge highlighted the property’s potential, stating, “We were very impressed by its past and future.” With antimony prices hitting new highs, Last Chance represents a compelling opportunity to unlock value through modern exploration techniques. Military Metals is poised for an active year, with plans to advance exploration across its portfolio. The company is prioritizing the Trojárová project, where it aims to complete a NI 43-101 resource estimate and initiate a preliminary economic assessment. Additionally, exploration programs at West Gore and Last Chance are expected to commence in Q2-Q3 2025, further solidifying the company’s position as an emerging player in the antimony sector. As one of the few publicly traded companies focused on antimony, Military Metals offers investors a unique opportunity to gain exposure to a strategically important resource with explosive demand and limited supply. With its diversified portfolio, experienced management team, and strategic projects in mining-friendly jurisdictions, the company is well-positioned to benefit from the global antimony supply crisis. Perpetua Resources Corp.: Perpetua Resources Corp. (Nasdaq: PPTA) is at the forefront of addressing the West’s critical antimony supply gap through its Stibnite Gold Project in Idaho. This ambitious project is not only one of the highest-grade open-pit gold deposits in the U.S. but also home to the only domestically mined source of antimony—a mineral deemed critical for national defense, energy storage, and advanced technology. With an estimated 148 million pounds of antimony reserves, the Stibnite Gold Project is expected to supply 35% of U.S. antimony demand in its first six years of operation, significantly reducing reliance on foreign suppliers like China and Russia. Antimony trisulfide from Stibnite is the only known domestic source capable of meeting U.S. defense needs for ammunition, missile systems, and other military applications. Perpetua’s project has already garnered significant government support, including a $59.2 million Defense Production Act Title III funding award to advance construction readiness and permitting. Perpetua’s vision extends beyond resource extraction; the Stibnite Gold Project is designed to restore an abandoned mining site, addressing decades of environmental damage. The company’s approved plan includes removing legacy waste to improve water quality, restoring river habitats, and reopening fish passages blocked for over 80 years. This commitment to environmental, social, and governance (ESG) principles has earned Perpetua widespread community and regulatory support, including a Final Record of Decision from the U.S. Forest Service after an eight-year permitting process. Economically, the project is a powerhouse. It has an estimated 4.8 million ounces of gold reserves and plans for an annual production of 300,000 ounces over a 15-year mine life. The Stibnite Gold Project is projected to generate over $3.7 billion in after-tax net present value (NPV) at current spot prices. The antimony by-product, priced at $21 per pound, enhances the project’s economics, with all-in sustaining costs (AISC) for gold projected at just $435 per ounce in the first four years of production. Furthermore, Perpetua is advancing partnerships to strengthen the domestic antimony supply chain. The company has collaborated with U.S. Antimony Corporation (NYSE: UAMY) to explore processing options for antimony concentrate, ensuring a fully American supply chain. Additionally, a procurement agreement with Idaho Power guarantees that the project will be powered by one of the lowest-carbon energy grids in the nation, aligning with Perpetua’s sustainability goals. United States Antimony Corp.: United States Antimony Corp. (NYSE: UAMY) is taking bold steps to diversify North America’s antimony supply chain, leveraging its mines and processing facilities to reduce reliance on foreign sources. The company produces essential antimony products, including antimony oxide, metal, and trisulfide, which are vital for industries such as defense, manufacturing, and energy storage. Recently, USAC relocated its corporate headquarters to Dallas, Texas, enhancing operational efficiency and exploring new mining opportunities. This move aligns with the company’s focus on expanding its footprint in North America. A key development is USAC’s exclusive option agreement to acquire 120 antimony mining claims in Alaska, covering approximately 17,900 acres with significant mineral potential. Supported by historic exploration data, this acquisition positions USAC to bolster domestic production capabilities and contribute to national security. Executive Vice President Joe Bardswich emphasized the importance of the deal, stating, “This agreement provides us with a unique opportunity to strengthen our ownership position in antimony deposits, which are critical to our nation’s security needs.” In Mexico, USAC is revitalizing its Madero smelter, with plans to process 100 tons of antimony ore per month. The refurbishment, including repairs to furnaces and air control systems, aims to improve efficiency and meet rising domestic demand. John Gustavsen, President of the Antimony Division highlighted the urgency of these efforts, noting, “Worldwide antimony prices continue to reach all-time highs, and we are working quickly to meet our nation’s growing demand.” USAC has also strengthened its leadership team with the appointment of two new vice presidents. Rodney Blakestad, Vice President of the Mining Division, brings over 45 years of experience in mineral exploration and development, while Leo Jackson, Vice President of the Mexican Antimony Division, offers decades of expertise in operations management and supply chain logistics. These appointments underscore USAC’s commitment to scaling its operations and optimizing production. As global demand for antimony continues to rise, USAC’s proactive measures—from expanding its mining portfolio to upgrading its processing facilities—highlight its potential as a key player in securing a reliable supply of this strategically important resource. By addressing vulnerabilities in the current supply chain, USAC is well-positioned to deliver value to investors while contributing to national security and industrial resilience. Nova Minerals Limited: Nova Minerals Limited (NASDAQ: NVA) is positioning itself as a key contender in the race to secure critical antimony supplies through its flagship Estelle Critical Minerals Project in Alaska. Located in the prolific Tintina Gold Belt, the Estelle Project spans 514 square km and hosts multiple high-grade antimony prospects, including the standout Stibium and Styx targets. With China controlling over 50% of global antimony production and recently banning exports to the U.S., Nova’s focus on domestic antimony development couldn’t be more timely. The Stibium prospect has emerged as a cornerstone of Nova’s antimony strategy. Recent exploration results have revealed an 800 m x 400 m high-grade antimony zone, with rock samples grading up to 56.7% antimony and soil samples showing concentrations as high as 2.8% antimony. These results confirm Stibium as a drill-ready target for 2025, with the potential to become a significant source of domestically mined antimony. Nova’s CEO, Christopher Gerteisen, highlighted the importance of the prospect, stating, “Defining an antimony resource at Stibium and advancing toward production is a top priority for the company.” Nova’s exploration success extends beyond Stibium. At the Styx prospect, rock samples have returned grades of up to 54.1% antimony, with a main vein occurrence measuring 50% stibnite (antimony sulfide). These discoveries underscore the Estelle Project’s potential to become a major supplier of antimony, which is essential for military ammunition, missile systems, flame retardants, and advanced electronics. To accelerate its antimony development, Nova is actively pursuing U.S. government support. As a member of the Defense Industrial Base Consortium (DIBC), the company is well-positioned to secure Department of Defense (DoD) grants aimed at strengthening domestic critical mineral supply chains. With China’s recent export restrictions, Nova’s Estelle Project is strategically positioned to address the growing supply gap and reduce reliance on foreign sources. Financially, Nova is taking proactive steps to fund its exploration and development programs. In early 2025, the company sold its non-core investment in Snow Lake Resources for $6.73 million, using the proceeds to reduce debt and strengthen its balance sheet. Additionally, the exercise of NASDAQ warrants brought in $0.79 million, further bolstering the company’s cash position. With $16 million in cash and no debt, Nova is well-funded to advance its 2025 exploration program, which includes resource drilling at Stibium and other antimony prospects. Disclaimers: RazorPitch Inc. "RazorPitch" is not operated by a licensed broker, a dealer, or a registered investment adviser. This content is for informational purposes only and is not intended to be investment advice. The Private Securities Litigation Reform Act of 1995 provides investors a safe harbor in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions, or future events or performances are not statements of historical fact and may be forward-looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. Forward-looking statements in this action may be identified through the use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements indicating certain actions & quote; may, could, or might occur. Understand there is no guarantee past performance will be indicative of future results. Investing in micro-cap and growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor's investment may be lost or impaired due to the speculative nature of the companies profiled. RazorPitch has been compensated to assist in the production and distribution of this content by MILIF. RazorPitch is responsible for the production and distribution of this content. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. This content is for informational purposes only; you should not construe any such information or other material as legal, tax, investment, financial, or other advice. Nothing contained in this article constitutes a solicitation, recommendation, endorsement, or offer by RazorPitch or any third-party service provider to buy or sell any securities or other financial instruments. All content in this article is information of a general nature and does not address the circumstances of any particular individual or entity. Nothing in this article constitutes professional and/or financial advice, nor does any information in the article constitute a comprehensive or complete statement of the matters discussed or the law relating thereto. RazorPitch is not a fiduciary by virtue of any persons use of or access to this content. Contact Details Mark McKelvie +1 585-301-7700 Mark@razorpitch.com Company Website http://razorpitch.com

February 25, 2025 07:00 AM Eastern Standard Time

Kadimastem and iTolerance Successfully Complete Pre-IND Meeting with the FDA for its Type 1 Diabetes Treatment

NLS Pharmaceutics

NLS Pharmaceutics Ltd. (Nasdaq: NLSP”) (“NLS”) and Kadimastem Ltd. (“Kadimastem”), a clinical-stage company specializing in "off-the-shelf" allogeneic cell therapy products for neurodegenerative diseases and diabetes, in collaboration with iTolerance Inc. (“iTolerance”), a U.S. based regenerative medicine company, announced today the result from the Type B pre-IND meeting held by Kadimastem and iTolerance with a committee of the U.S Food and Drug Administration (“FDA”) on February 24, 2025, regarding the development of iTOL-102, a potential cure for diabetes that would not require life-long chronic immune system suppression. iTOL-102 is an investigational biologic for the treatment and potential cure of Type 1 Diabetes consisting of Kadimastem’s allogenic human stem cell-derived pancreatic islets (IsletRx cells) combined with iTolerance’s immunomodulator (iTOL-100). Kadimastem and iTolerance believe that the completion of the pre-IND meeting is a significant milestone toward the clinical development of iTOL-102, an on-going collaborative research initiative between iTolerance and Kadimastem, funded in part by grants received from the Israel-U.S. Binational Industrial Research and Development Foundation. iTOL-102 was evaluated at the fast-track center for testing at the Diabetes Research Institute (“DRI”) at the University of Miami School of Medicine, where it was designated as a potential breakthrough transplantation approach for the treatment of Type 1 Diabetes, as the novel combination of tolerance-inducing agent and human stem cell-derived islets. iTOL-102 demonstrated functional insulin release and disease reversal in an animal model, with full compatibility between IsletRx cells and iTOL-100. Prior to the meeting with the FDA, Kadimastem and iTolerance received a preliminary response document from the FDA, providing critical feedback on their current preclinical and clinical development plans. This guidance is instrumental in moving forward with the next stages of development. Based on the feedback provided at the pre-IND meeting, Kadimastem and iTolerance are now updating their plans for a safety toxicology study and the preparation of a First-in-Human clinical trial. Kadimastem believes its collaboration with iTolerance signifies a potentially transformative step in diabetes treatment, paving the way towards the potential development of iTOL-100 and requesting regulatory approvals for commercialization of a potential cure for type 1 diabetes. iTOL-100 is an immunomodulatory microgel technology being developed by iTolerance designed to reduce or eliminate the need for life-long chronic systemic immunosuppression following transplantation of allogenic cells. In a preclinical diabetic rodent model designed by iTolerance, iTOL-100 was shown by iTolerance to be compatible with Kadimastem’s IsletRx human stem cell-derived islets. Kadimastem’s IsletRx is a clinical-grade product candidate comprising human pancreatic islet-like cells capable of secreting insulin. IsletRx, a preparation of human stem cell-derived islets developed by Kadimastem, is a scalable and virtually unlimited source of insulin-producing cells which could address the critical shortage of donor islets for transplantation. This innovative therapy may effectively detect glucose levels in the body and produce the necessary amounts of insulin and glucagon. Dr. Anthony Japour, Chief Executive Officer of iTolerance, commented, “I believe that the feedback from the FDA is a critical milestone in the development of iTOL-102, and we are encouraged by their support for our innovative approach to treating Type 1 diabetes. We believe that the successful outcome of this meeting validates our commitment to bring a game-changing therapy to patients, one that could ultimately eliminate the need for chronic life-long immunosuppression. We look forward to continuing our collaboration with Kadimastem and working closely with the FDA.” Alex Zwyer, CEO of NLS, commented, “I believe that the news demonstrates the strength of the proposed merger of NLS and Kadimastem and its technology platform to build a healthy, strong merged company that will benefit shareholders.” Kadimastem Executive Chairman and CEO Ronen Twito said, "The promising results from the fast-track center for testing at the DRI, combined with the comprehensive studies conducted by iTolerance and Kadimastem, enabled us to complete this important milestone. We are working closely with the FDA on the necessary steps needed to implement this potential innovative technology for patients with Type 1 diabetes and demonstrate a novel islet cell transplantation approach with no need for immunosuppression.” About Kadimastem Kadimastem is a clinical stage cell therapy company, developing "off-the-shelf", allogeneic, proprietary cell products based on its technology platform for the expansion and differentiation of Human Embryonic Stem Cells (hESCs) into functional cells. AstroRx®, the company's lead product, is an astrocyte cell therapy in clinical development for the treatment for ALS and in pre-clinical studies for other neurodegenerative indications. IsletRx is the company's treatment for diabetes. IsletRx is comprised of functional pancreatic islet cells producing and releasing insulin and glucagon, intended to treat and potentially cure patients with insulin-dependent diabetes. Kadimastem was founded by Professor Michel Revel, Chief Scientific Officer of the company and Professor Emeritus of Molecular Genetics at the Weizmann Institute of Science. Professor Revel received the Israel Prize for the invention and development of Rebif®, a multiple sclerosis blockbuster drug sold worldwide. Kadimastem is traded on the Tel Aviv Stock Exchange (TASE: KDST). About iTolerance, Inc. iTolerance is a regenerative medicine company developing technologies to enable tissue, organoid or cell therapy without requiring life-long immunosuppression. Leveraging its proprietary biotechnology-derived Streptavidin-FasL fusion protein/biotin-PEG microgel (SA-FasL microgel) platform technology, iTOL-100, iTolerance is advancing a pipeline of programs using both allogenic cadaveric and stem cell-derived pancreatic islet to potentially cure Type 1 diabetes. Utilizing iTOL-100 to induce local immune tolerance, the Company is developing its lead indication as a potential cure for Type 1 Diabetes without the need for life-long immunosuppression. Additionally, the Company is developing iTOL-201 for treating liver failure by utilizing hepatocytes and iTOL-401 as a nanoparticle formulation for large organ transplants without the need for life-long immunosuppression. For more information, please visit itolerance.com. We are a clinical-stage pharmaceutical company focused on the discovery and development of innovative therapies for patients with rare and complex central nervous system, or CNS, disorders, who have unmet medical needs. This press release contains expressed or implied forward-looking statements pursuant to U.S. Federal securities laws. For example, NLS and Kadimastem are using forward-looking statements when they discuss the belief that the results of the pre-IND meeting with the FDA demonstrates the strength of the proposed merger; that the meeting with the FDA is a significant milestone in the development of iTOL-102, and the expected benefits of iTOL-102 in the treatment of diabetes. These forward-looking statements and their implications are based on the current expectations of the management of NLS and Kadimastem and are subject to a number of factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. The following factors, among others, could cause actual results to differ materially from those described in the forward-looking statements: risks related to the companies’ ability to complete the merger on the proposed terms and schedule, including risks and uncertainties related to the satisfaction of the closing conditions related to the merger agreement and risks and uncertainties related to the failure to timely, or at all, obtain shareholder approvals for the transaction; unexpected costs, charges or expenses resulting from the transaction and potential adverse reactions or changes to business relationships resulting from the announcement or completion of the merger; changes in technology and market requirements; either or both companies may encounter delays or obstacles in launching and/or successfully completing their clinical trials; the companies’ products may not be approved by regulatory agencies; their technologies may not be validated as they progress and their methods may not be accepted by the scientific community; either of both of the companies may be unable to retain or attract key employees whose knowledge is essential to the development of their products; unforeseen scientific difficulties may develop with the products being advanced by the companies; their products may wind up being more expensive than anticipated; results in the laboratory may not translate to equally good results in real clinical settings; results of preclinical studies may not correlate with the results of human clinical trials; the companies’ patents may not be sufficient; their products may harm recipients; changes in legislation may adversely impact either or both of the companies; inability to timely develop and introduce new technologies, products and applications; and loss of market share and pressure on pricing resulting from competition, which could cause the actual results or performance of candidate products to differ materially from those contemplated in such forward-looking statements. Except as otherwise required by law, neither Kadimastem nor NLS undertakes any obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. More detailed information about the risks and uncertainties affecting NLS is contained under the heading “Risk Factors” in NLS’s annual report on Form 20-F for the year ended December 31, 2023, filed with the Securities and Exchange Commission (“SEC”), which is available on the SEC’s website, www.sec.gov, and in subsequent filings made by NLS with the SEC, including under the heading “Risk Factors” in NLS’s registration statement on Form F-4, filed with the SEC on December 27, 2024. This press release may include forward-looking information as defined in the Securities Law, 5728 – 1968. Forward-looking information is uncertain and mostly is not under Kadimastem’s control and the realization or non-realization of forward-looking information will be affected, among other things, by the risk factors characterizing the company's activity, as well as developments in the general environment and external factors affecting the company's activity. The company's results and achievements in the future may differ materially from any presented herein and the company makes no undertaking to update or revise such projection or estimate and does not undertake to update this document. This press release does not constitute a proposal to purchase the company's securities or an invitation to receive such offers. Investment in securities in general and in the company in particular bears risks. One should consider that past performance does not necessarily indicate performance in the future. No Offer or Solicitation: This communication is not intended to and shall not constitute an offer to buy or sell or the solicitation of an offer to buy or sell any securities, or a solicitation of any vote or approval, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offering of securities shall be made, except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended. Additional Information about the Transaction and Where to Find ItIn connection with the proposed transaction, NLS has filed a Registration Statement on Form F-4, including a proxy statement/prospectus, with the SEC. NLS may also file other relevant documents with the SEC regarding the proposed transaction. This document is not a substitute for the proxy statement/prospectus or any other document that NLS may file with the SEC. The proxy statement (if and when available) will be mailed or delivered to shareholders of NLS and Kadimastem. INVESTORS AND SECURITY HOLDERS ARE URGED TO READ THE PROXY STATEMENT/PROSPECTUS AND ANY OTHER RELEVANT DOCUMENTS THAT MAY BE FILED WITH THE SEC, AS WELL AS ANY AMENDMENTS OR SUPPLEMENTS TO THESE DOCUMENTS, CAREFULLY AND IN THEIR ENTIRETY IF AND WHEN THEY BECOME AVAILABLE BECAUSE THEY CONTAIN OR WILL CONTAIN IMPORTANT INFORMATION ABOUT THE PROPOSED TRANSACTION. Investors and security holders will be able to obtain free copies of the proxy statement/prospectus (if and when available) and other documents containing important information about NLS and Kadimastem and the proposed transaction, once such documents are filed with the SEC through the website maintained by the SEC at http://www.sec.gov. Copies of the documents filed with the SEC by the Company will be available free of charge on NLS’s website at www.nlspharma.com. Participants in the Solicitation: NLS, Kadimastem, and certain of their respective directors and executive officers may be deemed to be participants in the solicitation of proxies from NLS and Kadimastem shareholders in respect of the proposed transaction. Information about the directors and executive officers of NLS, including a description of their direct or indirect interests, by security holdings or otherwise, is set forth in NLS’s Annual Report on Form 20-F for the fiscal year ended December 31, 2023, which was filed with the SEC on May 15, 2024. Other information regarding the participants in the proxy solicitation and a description of their direct and indirect interests, by security holdings or otherwise, will be contained in the proxy statement/prospectus and other relevant materials to be filed with the SEC regarding the proposed merger when such materials become available. Investors should read the proxy statement/prospectus carefully when it becomes available before making any voting or investment decisions. You may obtain free copies of these documents from NLS Pharmaceutics using the sources indicated above. Contact Details NLS Pharmaceutics Ltd. NLS Pharmaceutics Ltd. +41 44 512 21 50 contact@nls-pharma.com Kadimastem Ltd. Sarah Bazak +972 73-797-1615 s.bazak@kadimastem.com Company Website https://nlspharmaceutics.com/

February 25, 2025 07:00 AM Eastern Standard Time

Image

Robertson Stephens Launches Family Office for Select Clients

Robertson Stephens

Robertson Stephens today announced that it has hired Bruce Stewart to launch a family office that will serve select ultra-high-net-worth clients who have outgrown a multi-family office platform but are not ready to transition to a pure single-family office environment. As Head of Family Office at Robertson Stephens, Stewart brings over 25 years of experience in building and advising single-family offices, as well as serving as an outsourced chief investment officer. In this role, he will develop a practice designed for families with more sophisticated needs than those typically addressed by traditional multi-family offices. “We have always planned to have a family office service offering adjacent to our wealth management practice,” said Raj Bhattacharyya, Chief Executive Officer of Robertson Stephens. “With the launch of our family office, clients have the rare opportunity to access unique and highly valuable services beyond the standard offering seen in traditional private banks, multi-family offices and many other players in the industry without the upfront and high recurring expenses typical of a single-family office. Bruce is not only a deep expert in this space, he has also demonstrated his ability to build out successful single-family offices over the past few years.” Before Robertson Stephens, Stewart was the founder and Managing Partner of Spartan Risk Solutions (SRS), a discreet family-office consultancy specializing in the development of family offices and outsourced chief investment officer solutions. In this role, Stewart built and managed $23 billion in wealth for four families. Previously, Stewart was the global head of investments for Bank of New York Family Office, where he led an investment team managing nearly $15 billion in assets. His other leadership roles include having served as President of BNY Mellon Canada and co-head of investments at Toronto Dominion Bank. “I’m grateful to Robertson Stephens for this opportunity to build out this first-of-its-kind service,” Stewart said. "In my experience, some families have outgrown the capabilities of a traditional multi-family office but prefer to avoid the financial commitment of establishing their own. These families have more complex needs that require a specialized skill set, enhanced capabilities, and a sophisticated approach. I’m excited to build this practice at Robertson Stephens and deliver a truly differentiated solution." Contact Details Peter Page ppage@vocatusllc.com Company Website https://rscapital.com/

February 24, 2025 12:33 PM Eastern Standard Time

Robertson Stephens Launches Family Office for Select Clients

Robertson Stephens

Robertson Stephens today announced that it has hired Bruce Stewart to launch a family office that will serve select ultra-high-net-worth clients who have outgrown a multi-family office platform but are not ready to transition to a pure single-family office environment. As Head of Family Office at Robertson Stephens, Stewart brings over 25 years of experience in building and advising single-family offices, as well as serving as an outsourced chief investment officer. In this role, he will develop a practice designed for families with more sophisticated needs than those typically addressed by traditional multi-family offices. “We have always planned to have a family office service offering adjacent to our wealth management practice,” said Raj Bhattacharyya, Chief Executive Officer of Robertson Stephens. “With the launch of our family office, clients have the rare opportunity to access unique and highly valuable services beyond the standard offering seen in traditional private banks, multi-family offices and many other players in the industry without the upfront and high recurring expenses typical of a single-family office. Bruce is not only a deep expert in this space, he has also demonstrated his ability to build out successful single-family offices over the past few years.” Before Robertson Stephens, Stewart was the founder and Managing Partner of Spartan Risk Solutions (SRS), a discreet family-office consultancy specializing in the development of family offices and outsourced chief investment officer solutions. In this role, Stewart built and managed $23 billion in wealth for four families. Previously, Stewart was the global head of investments for Bank of New York Family Office, where he led an investment team managing nearly $15 billion in assets. His other leadership roles include having served as President of BNY Mellon Canada and co-head of investments at Toronto Dominion Bank. “I’m grateful to Robertson Stephens for this opportunity to build out this first-of-its-kind service,” Stewart said. "In my experience, some families have outgrown the capabilities of a traditional multi-family office but prefer to avoid the financial commitment of establishing their own. These families have more complex needs that require a specialized skill set, enhanced capabilities, and a sophisticated approach. I’m excited to build this practice at Robertson Stephens and deliver a truly differentiated solution." About Robertson Stephens Robertson Stephens Wealth Management, LLC is an independent SEC-registered investment advisor. Registration does not imply any specific level of skill or training and does not constitute an endorsement of the firm by the Commission. Its mission is to transform the wealth management experience by delivering institutional-quality investment solutions, comprehensive wealth planning, and intelligent digital solutions all within a fiduciary relationship where the client is our highest priority. Robertson Stephens AUM is as of December 2024. For more information about Robertson Stephens, please visit: https://www.rscapital.com. Contact Details Peter Page ppage@vocatusllc.com Company Website https://rscapital.com/

February 24, 2025 12:05 PM Eastern Standard Time

News Release

Where is WOW Vegas Legal in the US?

Acroud Media

WOW, Vegas Casino has been one of the online social casinos for a while, offering fantastic no-deposit offers, casino-style games, and more. It has certainly made its mark, attracting players from across the US thanks to its incredible customer features. The brand's priority is to please players. Where is WOW Vegas Legal? Players aged 18+ can visit WOW Vegas Casino from all US states. However, at this current time, the states of Washington, Idaho, Nevada, and Michigan, are excluded and do not accept online Social, or Sweepstakes Casinos. Despite the restricted states, WOW Vegas is largely accessible in comparison to a traditional casino site. As well as the broad legality of WOW Vegas, another key aspect to remember is that to register and participate in activities at WOW Vegas Casino, individuals must be 18 years or older and reside in a state not subject to the four aforementioned restrictions. Our Expert Review of WOW Vegas WOW Vegas Casino stands as a mecca for exemplary casino-style experiences and entertainment within the online casino industry. Recognized for its enthralling features and immersive gameplay, WOW Vegas delivers an exhilarating experience to players across the US, featuring a diverse selection of state-of-the-art games, spanning from traditional table games to inventive slots and live dealer options. Its intuitive interface and seamless navigation elevate the overall experience, ensuring players can explore and enjoy its extensive offerings effortlessly. Backed by rigorous security measures, players can engage in their favorite games with assurance, confident that their information remains protected. Furthermore, WOW Vegas offers many enticing promotions catering to loyal players and newcomers alike. Being a social site, WOW Vegas does not offer real money play; instead, virtual currencies known as WOW and Sweeps Coins are utilized to access free casino-style games and redeem prizes. Partaking in WOW Vegas is entirely free, so users do not have to risk their hard-earned cash. Create an account with WOW Vegas Casino today! Restricted States for WOW Vegas Idaho Michigan Nevada Washington 18+ Please Play Responsibly. Gambling Problem? Call or text 1-800-GAMBLER Why is WOW Vegas Restricted? Despite being widely legal across the US, WOW Vegas Casino is still restricted in states including Idaho, Michigan, Nevada, and Washington because of differing legal regulations concerning online gambling that vary from state to state. Each state maintains its unique laws and policies governing gambling activities, and some states enforce strict regulations or complete prohibitions on online gambling, while others adopt more lenient laws. Concerns regarding addiction, consumer protection, and adherence to state gambling policies influence these restrictions. For example, regardless of whether it is a social site or a traditional casino, Washington does not allow any form of gambling. Thus, the varying legal landscape across states dictates the accessibility and operation of online casinos like WOW Vegas Casino. Legalities of Social Casinos US Our valued readers may need to be made aware of the laws surrounding social casino sites like WOW Vegas. Therefore, our experts are here to provide a simple explanation of the legalities surrounding WOW Vegas and social sites alike. One of the main differences between traditional sites and social casinos is the lack of real money play. WOW Vegas utilizes WOW Coins and Sweeps Coins in place of cash. WOW, Coins can be used to access free casino-style games and can be purchased via coin packages or won through bonuses. Sweep Coins cannot be purchased; they can only be won unless players receive additional Sweep Coins within their WOW Coin packages. Sweep coins are used for accessing games as well as redeeming prizes like real cash. Therefore, partaking in social casinos is entirely free unless users wish to purchase coin packages. Additionally, the minimum gambling age for social sites like WOW Vegas is lower than traditional casinos, at 18+. To be eligible to create an account with a social casino site, users must ensure they are residing in a non-restricted state and are aged 18+. FAQs Is WOW Vegas Casino Safe? Players can rest assured that WOW Vegas Casino is highly safe and has received valid licensing and certification from reliable licensing bodies. Additionally, WOW Vegas adopts SSL data encryption technology to protect all user data and information. Where Can I access WOW Vegas? WOW Vegas is legal in all US states, excluding Nevada, Michigan, Idaho, and Washington. Is there a WOW Vegas App? There is currently no WOW Vegas Casino mobile app; however, players can enjoy the fully optimized WOW Vegas mobile site for iOS and Android devices. Users can find their favorite casino games and generous customer bonuses here. [toc] Contact Details Acroud Media info-media@acroudmedia.com

February 24, 2025 09:10 AM Eastern Standard Time

TriSpan Closes Continuation Vehicle for Prestige PEO Holdings

PrestigePEO

TriSpan LLP (“TriSpan”), a New York and London based private equity firm, is pleased to announce the closing of a single-asset continuation vehicle that acquired interests in Prestige PEO Holdings LP (“Prestige” or the “Company”). The transaction was led by growth equity firm Lead Edge Capital, and supported by a diverse group of existing investors, including a substantial investment from affiliates of TriSpan. The transaction will provide follow-on capital to support Prestige through its next phase of growth and value creation. Prestige is the parent company of PrestigePEO, a provider of comprehensive, outsourced human resource services to small and mid-size businesses in the United States. Since TriSpan’s original investment in 2020, Prestige has grown organically utilizing its differentiated broker model while also successfully completing five strategic acquisitions and expanding into attractive geographies. “We are thrilled to continue our collaboration with TriSpan as we continue to capitalize on a tremendous market opportunity in our next phase of growth,” said Andy Lubash, CEO and Founder of Prestige. “Our partnership with TriSpan has been core to our success and we believe we are well-positioned to continue to gain market share and unlock the full growth potential of the platform.” “Prestige’s talented leadership team and its ability to access the broker channel for new client acquisitions has driven strong performance to-date and will continue to be an accelerator of growth in the future,” said Baudoin Lorans, Partner at TriSpan. “The Company’s high-touch, customer centric approach delivers substantial value to its clients and leads to impressive retention. We are delighted to continue our partnership with the Company and its leadership team.” “We are excited to partner with Prestige and TriSpan on this next phase of expansion,” said Tim Bemer, Partner at Lead Edge. “For over two decades, Prestige has demonstrated an impressive track record of efficient growth and high client satisfaction, driven by a strong leadership team and unique go-to-market strategy.” Lazard Frères & Co. LLC served as financial advisor and Goodwin Procter LLP served as legal counsel to TriSpan. A separate team of attorneys at Goodwin Procter LLP served as legal counsel to Lead Edge on the transaction. Atlantic Global Risk LLC served as the R&W insurance broker for the transaction and a fairness opinion was provided by Houlihan Lokey Capital Inc. About Prestige Prestige PEO Holdings, LLC is the parent company of Prestige Employee Administrators, also known as PrestigePEO. Prestige empowers small and mid-sized businesses to simplify HR by offering end-to-end support for employee benefits management, payroll administration, workers’ compliance, HR guidance, and more. Merging the power of industry-leading customer service with innovative technology options, Prestige delivers a full spectrum of HR services and solutions to help SMBs lower employee benefit costs, reduce administrative workloads, and manage critical HR functions. Prestige is among only 1% of PEOs that are ESAC-accredited, Workers Comp Risk Management (CI)-certified, and classified as a Certified Professional Employer Organization (CPEO) by the IRS – demonstrating financial stability and strict adherence with a diverse range of regulatory and security standards. Headquartered in Melville, NY, Prestige is licensed to support SMBs nationwide. For more on Prestige, visit www.prestigepeo.com. Follow the Company on Facebook, X, LinkedIn, Instagram, and YouTube. About TriSpan Founded in 2015, TriSpan, LLP is a private equity firm with offices in New York and London that invests in middle market companies in North America, Europe, and the United Kingdom. TriSpan, LLP is committed to creating value through using a combination of deep operational and financial resources to accelerate growth and drive improved performance. Since inception, the firm has completed 24 platform investments, alongside nearly 100 bolt-on acquisitions across its portfolio. For more information, please visit Trispanllp.com. About Lead Edge Capital Lead Edge Capital is a $5 billion growth equity firm investing in software, internet, and tech-enabled businesses globally. The firm has invested in a number of major software and internet companies around the world, including Alibaba Group, Arrive Logistics, Asana, Azul Systems, Bazaarvoice, Benchling, Clearscore, Duo Security, Grafana, GrowthZone, Holistiplan, LeanStaffing, LiveView Technologies, Pacemate, SafeSend, Signal Sciences, Tempo, Toast, Wise, and YouSign. One of the main drivers of Lead Edge’s success is its unique investor base, a network of 700+ executives, entrepreneurs, and dealmakers who have built and run some of the world’s most successful companies. In addition to providing flexible capital, Lead Edge leverages this global advisory group to connect portfolio companies with the customers, partners, talent, and advisors needed to accelerate growth. Lead Edge Capital was founded in 2011 and has offices in New York City, London and Santa Barbara. Contact Details Prestige PEO Holdings, LLC Jay Zamft +1 516-692-8505 jzamft@prestigepeo.com Company Website https://www.prestigepeo.com/

February 24, 2025 09:00 AM Eastern Standard Time

Elluminex (ELX): New Decentralized Exchange Spearheading DeFi Revolution On Toncoin Nertwork

Elluminex

The decentralized finance space has changed over the years and appears ready to replace traditional finance institutions, which have faced significant regulatory scrutiny, security, and privacy issues. According to Forbes, the DeFi market could explode to over $450B by 2030, which is more than 300% growth from its current market size. Elluminex (ELX) is ideally positioned to grab a share of this growing market thanks to its revolutionary DeFi hub on the TON blockchain. This new project could transform the largely untapped Toncoin network, much like how Jupiter (JUP) revolutionized Solana to become one of the dominant players in DeFi. Since Jupiter's launch, Solana has become a goldmine of explosive meme coin opportunities. Now, market participants anticipate that TON could benefit from its Jupiter-like platform―Elluminex (ELX). Let’s find the possibilities! Elluminex (ELX) To Drive DeFi Adoption On Toncoin Network Despite being among the fastest-growing blockchains, Toncoin is underdeveloped, mainly in terms of the DeFi landscape. However, this might soon change, thanks to Elluminex (ELX). The DeFi platform seeks to leverage the over 950 million users in the network to bring DeFi to the blockchain, transforming it and taking its capabilities and vast reach to the next level. The altcoin seeks to combine fragmented liquidity and leverage TON’s scalability and speed to power cross-chain swaps across 40 networks. Therefore, traders on TON will access liquidity from major networks. This increased liquidity will ensure a more efficient trading experience, minimizing slippage, which is critical for traders since slippage usually eats into profits. This will, in turn, stabilize prices in the TON ecosystem. With this view, more developers could launch on the chain. Jupiter brought this to the Solana network when it launched. Additionally, the project’s non-custodial approach, which does not require rigorous KYC processes, enables users to retain complete control over their assets. What Features Are Triggering Elluminex Adoption? Elluminex seeks to provide a seamless and user-friendly platform that allows users to trade, stake, farm, bridge, and track their portfolios. By combining these features in a single unified platform, Elluminex could open up the DeFi space for beginners and experienced users. The decentralized exchange enables users to trade an array of crypto assets from their wallets to ensure security and control. To empower informed decision-making, Elluminex features an AI portfolio tracker that enables traders to monitor, analyze, and gain insights into their assets’ performance. It also has a comprehensive educational academy that helps users broaden their knowledge of Decentralized finance (DeFi). Additionally, the platform has a pre-market access feature, where users gain early access to new TON projects through an over-the-counter platform before they are officially launched on significant exchanges. This opens the door to opportunities for traders to enter high-potential projects at the nascent stage. Outside of that, users can earn rewards by staking the token and offering liquidity to the ecosystem. ELX Token Set For Exponential Rallies The ELX token will power significant processes within its ecosystem, including governance and staking rewards. At the ongoing presale, Elluminex is selling for only $0.06. Given its innovative features and a focus on accessibility, Elluminex could see exponential growth before the end of its presale, positioning it among the best crypto to watch in 2025. The presale just started a few weeks ago, and Elluminex has already raised over $300,000 in ICO funding. This attests to its growing demand and growth potential. Now could be the best time to join the Elluminex revolution, as it stands a chance of making massive returns. With its cross-chain capabilities and TON’s affiliation with Telegram's nearly 1 billion users, ELX's price will likely skyrocket in the months ahead. This makes it the best DeFi coin to buy now. Join the community and make Elluminex part of your portfolio today! Website: elluminex.com/ X (Twitter): https://x.com/elluminex Telegram: https://t.me/Elluminex YouTube: https://www.youtube.com/@Elluminex Elluminex is unique in that it is bringing DeFi to the TON Network/Blockchain which at the moment is very limited in this sense with very few options available to its users. Despite this the TON Network is still the fastest growing blockchain in the world and many view it as a future powerhouse to rival Bitcoin, Ethereum and Solana. By bringing DeFi to the TON Network, it would immediately transform the chain and take its capabilities and vast reach to the next level. (ELX is a transformative crypto for the TON chain) Simply having lots of token holders and liquidity means nothing if project owners, developers are not able to tap into and utilise it, and crypto users are not able to trade it freely and seamlessly. Cryptocurrency may be unregulated in your jurisdiction. The value of cryptocurrencies fluctuates and it is important that you thoroughly understand the risks associated with acquiring cryptocurrencies, as outlined in the Disclaimer. You confirm that you are not a citizen or resident of the United States, United Kingdom, or any prohibited jurisdiction, or any other location where the purchase of Elluminex and $ELX token may be legally restricted. Please note that our list of restricted countries and terms of service may undergo updates, and it is your responsibility to stay informed about the latest version. By proceeding to continue to use Elluminex.com, you acknowledge and agree to our Terms of Use and Privacy Policy. Contact Details Elluminex Andy press@elluminex.com Company Website https://elluminex.com/

February 24, 2025 07:31 AM Eastern Standard Time

Image

News Release

World Mobile Recognized as ITB Innovator 2025 for Transforming Global Travel Connectivity

Rev Up Marketers

World Mobile has been named an ITB Innovator 2025 by ITB Berlin, the world’s leading travel trade show, in recognition of its groundbreaking advancements in travel technology. This prestigious honor highlights World Mobile’s role in redefining global travel connectivity through its unlimited travel eSIM, which offers seamless, high-speed internet access across more than 120 countries. With international travel on the rise, the demand for reliable, cost-effective connectivity has never been greater. Traditional roaming fees, SIM card swaps, and unreliable public Wi-Fi have long been pain points for travelers. World Mobile has addressed these challenges by establishing partnerships with over 250 mobile networks worldwide, ensuring a seamless and uninterrupted internet experience for users. Haim Boukai, Senior VP of Business Development at World Mobile, described the recognition as a validation of the company’s commitment to revolutionizing travel connectivity. He emphasized that in an increasingly digital world, staying connected should be effortless, affordable, and worry-free. Unlike traditional SIM cards and many existing eSIM solutions, World Mobile’s technology enables travelers to stay online without concern about data limits, hidden fees, or unreliable connections. By automatically connecting to the strongest available local network, it provides uninterrupted global access, setting a new standard for travel connectivity. The ITB Innovator 2025 award not only underscores World Mobile’s leadership in travel technology but also presents a valuable opportunity for airlines, travel agencies, and hospitality providers to integrate seamless eSIM solutions into their services. As the demand for digital solutions grows, travel businesses can enhance customer experience and offer a more connected journey. Looking ahead, World Mobile is actively investing in next-generation connectivity solutions, including AI-driven network optimization, enhanced 5G integration, and strategic partnerships with major travel platforms. With a commitment to continuous innovation, the company remains at the forefront of digital transformation in the travel industry. About World Mobile Founded in 2019, World Mobile is a leading provider of global travel connectivity solutions. By leveraging cutting-edge eSIM technology and strategic partnerships with over 250 mobile networks, the company ensures seamless, high-speed internet access across more than 120 countries. Its unlimited travel eSIM is designed to eliminate the complexities of traditional roaming, offering travelers an affordable and hassle-free way to stay connected. For more detail Visit: https://www.worldmobile.com/ Contact Details World Mobile Haim Boukai affiliate@worldmobile.com Company Website https://www.worldmobile.com/

February 24, 2025 05:55 AM Eastern Standard Time

All Industries

Argo Living Soils (CSE: ARGO) (OTC: ARLSF): Positioned for Growth in a $31.35 Billion Industry

Riding the Antimony Wave: 4 Stocks to Watch as Prices Hit Record Highs

Kadimastem and iTolerance Successfully Complete Pre-IND Meeting with the FDA for its Type 1 Diabetes Treatment

Robertson Stephens Launches Family Office for Select Clients

Robertson Stephens Launches Family Office for Select Clients

Where is WOW Vegas Legal in the US?

TriSpan Closes Continuation Vehicle for Prestige PEO Holdings

Elluminex (ELX): New Decentralized Exchange Spearheading DeFi Revolution On Toncoin Nertwork

World Mobile Recognized as ITB Innovator 2025 for Transforming Global Travel Connectivity